Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details) - Schedule of warrant activities

v3.23.1
Shareholders' Deficit (Details) - Schedule of warrant activities - Warrant [Member] - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Shareholders' Deficit (Details) - Schedule of warrant activities [Line Items]    
Number of Warrants, Beginning balance 17,500,000 2,050,000
Weighted Average Exercise Price, Beginning balance $ 0.05 $ 0.05
Weighted Average Remaining Contractual Term (Years), Beginning balance 4 years 8 months 1 day 3 years 7 months 28 days
Aggregate Intrinsic Value, Beginning balance $ 137,000
Number of Warrants, Granted 33,000,000 16,500,000
Weighted Average Exercise Price, Granted $ 0.025 $ 0.05
Weighted Average Remaining Contractual Term (Years), Granted
Aggregate Intrinsic Value, Granted
Number of Warrants, Cancelled (16,500,000) (1,050,000)
Weighted Average Exercise Price, Cancelled $ 0.05 $ (0.01)
Weighted Average Remaining Contractual Term (Years), Cancelled
Aggregate Intrinsic Value, Cancelled
Number of Warrants, Balance Outstanding, Ending balance 34,000,000 17,500,000
Weighted Average Exercise Price, Balance Outstanding, Ending balance $ 0.011 $ 0.05
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending balance 3 years 8 months 23 days 4 years 8 months 1 day
Aggregate Intrinsic Value, Balance Outstanding, Ending balance
Number of Warrants, Exercisable 34,000,000  
Weighted Average Exercise Price, Exercisable $ 0.011  
Weighted Average Remaining Contractual Term (Years), Exercisable 3 years 8 months 23 days  
Aggregate Intrinsic Value, Exercisable